Litcius/Paper detail

Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients – insights on the risk of acquisition and CRE infection

Maristela Pinheiro Freire, Laína Bubach Carvalho, José Otto Reusing, Fernanda Spadão, Max Igor Banks Ferreira Lopes, William C. Nahas, Elias David‐Neto, Lı́gia Camera Pierrotti

2021Infectious Diseases16 citationsDOI

Abstract

Background Kidney transplant recipients are a risk group for carbapenem-resistant Enterobacteriaceae infection.Objectives This study aimed to identify risk factors for CRE acquisition and infection among kidney transplant recipients.Methods We conducted a case-control study; we defined the case as kidney transplant recipient with positive culture for carbapenem-resistant Enterobacteriaceae identified between January 2010 and February 2019. Controls were chosen among kidney transplant recipients hospitalized in the same period of cases (1:2). Surveillance culture for carbapenem-resistant Enterobacteriaceae was performed at admission and weekly during hospital stay. The risk factors analysis for carbapenem-resistant Enterobacteriaceae infection was performed among patients colonized by these bacteria.Results We identified 331 patients colonized with carbapenem-resistant Enterobacteriaceae; The median time from transplantation to first carbapenem-resistant Enterobacteriaceae positive culture was 42 days (range from 3 to 7399 days); 125(37.8%) patients developed infection; the most common site was urinary tract. Risk factors for carbapenem-resistant Enterobacteriaceae acquisition were recipient age >45-year, diabetes nephropathy, donor age >55-year, ureteral stent at kidney transplantation, delay of graft function, median lymphocytes count <800cells/mm3, and acute cellular rejection. Risk factors for carbapenem-resistant Enterobacteriaceae infection were recipient age at CRE acquisition >50-year; median lymphocytes count ≤700 cells/mm3, carbapenem use, and colonization by polymyxin-resistant strain. Patients colonized by polymyxin and carbapenem resistant Enterobacteriaceae strain who used carbapenem had a 93.8% probability of developing infection by this agent.Conclusion Carbapenem-resistant Enterobacteriaceae acquisition after kidney transplant is related to graft conditions, immunosuppression degree. Among carbapenem-resistant Enterobacteriaceae colonized patients, special attention is needed for those harbouring polymyxin-resistant strains.

Topics & Concepts

EnterobacteriaceaeCarbapenem-resistant enterobacteriaceaeMedicineCarbapenemKidney transplantationImmunosuppressionTransplantationInternal medicineMicrobiologyInfection controlAntibioticsIntensive care medicineBiologyEscherichia coliGeneBiochemistryAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyRenal Transplantation Outcomes and Treatments
Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients – insights on the risk of acquisition and CRE infection | Litcius